This ACES 2011 yearbook celebrates the achievements of Europe’s academic entrepreneurs, and charts Europe’s progress in building a new culture of innovation on campus.
At the third in a series of high-level academic policy debates on the energy R&D challenge, The Energy Difference, key ideas and recommendations have emerged on how to plan a sustainable and cost-effective energy future for Europe.
This report combines new research and analysis on open innovation with focused interviews of major participants in the European innovation system. The recommendations comprise an informal ‘charter’ for EU open innovation policy. The study was conducted by Prof. Henry Chesbrough of ESADE Business School and the University of California, Berkeley and Prof. Wim Vanhaverbeke, of ESADE in Barcelona, Vlerick Management School and the University of Hasselt, in Belgium.
At the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference, key ideas and recommendations have emerged to accelerate the deployment of sustainable biofuels.
This Science|Business report summarizes the first in a series of three high-level academic policy debates, focused on the energy R&D challenge. Twelve key ideas and recommendations emerged to better leverage Europe's research potential and speed the development of new energy technologies
When it comes to healthcare, if the US and Europe worked together they could cut costs, spur innovation, and tackle their common health problems, according to a group of experts that met in Washington DC.
The European Commission is planning new policies to ‘modernise’ universities. The Science|Business Innovation Board calls on the EU to push for universities that are more flexible, responsive and autonomous actors in the knowledge marketplace
On 3 December 2011, the ACES Selection Committee met at ESADE’s Creapolis technology and innovation park in Barcelona to sort through the 120 nominations received.
Science|Business and Sweden’s Karolinska Institutet have conducted a survey of a wide range of stakeholders in personalised healthcare across four major EU-markets (Belgium, France, the Netherlands and the UK).
